C13orf42
gene geneOn this page
Summary
C13orf42 (chromosome 13 open reading frame 42, HGNC:42693) is a protein-coding gene on chromosome 13q14.3, encoding Uncharacterized protein C13orf42 (A0A1B0GVH6).
At a glance
- GWAS associations: 3
- MANE Select transcript:
NM_001351589
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:42693 |
| Approved symbol | C13orf42 |
| Name | chromosome 13 open reading frame 42 |
| Location | 13q14.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000226792 |
| Ensembl biotype | protein_coding |
| Entrez | 647166 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding_CDS_not_defined, 1 protein_coding
ENST00000433280, ENST00000563710, ENST00000569306, ENST00000636098
RefSeq mRNA: 1 — MANE Select: NM_001351589
NM_001351589
CCDS: CCDS86352
Canonical transcript exons
ENST00000563710 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001802918 | 51110796 | 51111274 |
| ENSE00002617847 | 51082119 | 51084325 |
| ENSE00003795854 | 51087928 | 51088075 |
| ENSE00003795862 | 51085319 | 51085559 |
Expression profiles
Bgee: expression breadth broad, 52 present calls, max score 86.06.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0413 / max 11.4203, expressed in 20 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 137370 | 0.0413 | 20 |
Top tissues by expression
116 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.06 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.01 | silver quality |
| cerebellar vermis | UBERON:0004720 | 73.66 | gold quality |
| quadriceps femoris | UBERON:0001377 | 69.42 | gold quality |
| thymus | UBERON:0002370 | 63.49 | silver quality |
| colonic epithelium | UBERON:0000397 | 58.36 | gold quality |
| mucosa of stomach | UBERON:0001199 | 50.86 | gold quality |
| spleen | UBERON:0002106 | 47.29 | gold quality |
| adenohypophysis | UBERON:0002196 | 46.49 | gold quality |
| testis | UBERON:0000473 | 46.01 | gold quality |
| pituitary gland | UBERON:0000007 | 45.91 | gold quality |
| right testis | UBERON:0004534 | 45.75 | gold quality |
| left testis | UBERON:0004533 | 44.00 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 40.81 | gold quality |
| temporal lobe | UBERON:0001871 | 40.23 | gold quality |
| amygdala | UBERON:0001876 | 40.07 | gold quality |
| prefrontal cortex | UBERON:0000451 | 38.89 | silver quality |
| granulocyte | CL:0000094 | 38.59 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.17 | gold quality |
| calcaneal tendon | UBERON:0003701 | 37.01 | gold quality |
| Ammon’s horn | UBERON:0001954 | 36.59 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| gall bladder | UBERON:0002110 | 35.78 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 35.64 | gold quality |
| placenta | UBERON:0001987 | 35.42 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 35.20 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 34.90 | gold quality |
| frontal cortex | UBERON:0001870 | 34.51 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.57 |
| E-MTAB-6058 | no | 10.78 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm4131 | ENSMUSG00000100486 |
| rattus_norvegicus | C15h13orf42 | ENSRNOG00000070558 |
Protein
Protein identifiers
Uncharacterized protein C13orf42 — A0A1B0GVH6 (reviewed: A0A1B0GVH6)
All UniProt accessions (1): A0A1B0GVH6
RefSeq proteins (1): NP_001338518* (*=MANE)
Domains & families (InterPro)
UniProt features (2 total): chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A1B0GVH6-F1 | 52.75 | 0.06 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr13q14
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
18 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| C13orf42 | STON1 | Q9Y6Q2 | 593 |
| C13orf42 | BBS9 | P78514 | 398 |
| C13orf42 | EIF4G3 | O43432 | 394 |
| C13orf42 | ADGRV1 | Q8WXG9 | 359 |
| C13orf42 | ZBTB20 | Q9HC78 | 356 |
| C13orf42 | FHIT | P49789 | 272 |
| C13orf42 | TP63 | Q9H3D4 | 250 |
| C13orf42 | RYR2 | Q92736 | 223 |
| C13orf42 | WLS | Q5T9L3 | 174 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A140LFM6, A0A1B0GVH6, A0A1L8H8C0, A0A2K1JJ00, A0JMD2, A2ARZ3, A2AWL7, A4IGV6, A6H5Y1, D3ZJ47, E9Q309, F1QPR4, F5H4B4, H0WFA5, O14513, O35413, O94875, P0CAX8, P48437, Q12912, Q15468, Q1LXZ9, Q1X8D7, Q28FG2, Q3UTJ2, Q3ZBS1, Q499E5, Q49A88, Q4V7H1, Q5T5U3, Q5VT06, Q62417, Q62770, Q69Z38, Q6DFB0, Q80TY4, Q8BLN6, Q8CB14, Q8IWI9, Q8K0T7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
2142 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 13:51085521:A:G | W201R | 0.996 |
| 13:51085521:A:T | W201R | 0.996 |
| 13:51110935:A:G | L92P | 0.993 |
| 13:51110924:G:T | R96S | 0.992 |
| 13:51110944:A:G | L89P | 0.989 |
| 13:51085382:A:G | L247S | 0.987 |
| 13:51085519:C:A | W201C | 0.987 |
| 13:51085519:C:G | W201C | 0.987 |
| 13:51110923:C:G | R96P | 0.987 |
| 13:51110923:C:A | R96L | 0.986 |
| 13:51085549:G:C | S191R | 0.984 |
| 13:51085549:G:T | S191R | 0.984 |
| 13:51085551:T:G | S191R | 0.984 |
| 13:51085379:G:T | P248H | 0.983 |
| 13:51111102:G:C | S36R | 0.979 |
| 13:51111102:G:T | S36R | 0.979 |
| 13:51111104:T:G | S36R | 0.979 |
| 13:51085520:C:G | W201S | 0.978 |
| 13:51085522:G:C | N200K | 0.978 |
| 13:51085522:G:T | N200K | 0.978 |
| 13:51110915:A:C | Y99D | 0.978 |
| 13:51088027:C:G | A155P | 0.977 |
| 13:51085375:C:A | K249N | 0.976 |
| 13:51085375:C:G | K249N | 0.976 |
| 13:51085380:G:T | P248T | 0.976 |
| 13:51088011:T:A | D160V | 0.976 |
| 13:51085396:C:A | R242S | 0.975 |
| 13:51085396:C:G | R242S | 0.975 |
| 13:51085380:G:A | P248S | 0.972 |
| 13:51085343:A:G | F260S | 0.971 |
dbSNP variants (sampled 300 via entrez): RS1000002405 (13:51142808 A>C), RS1000060831 (13:51101751 T>C), RS1000116204 (13:51108038 G>C), RS1000119009 (13:51163113 G>A), RS1000151647 (13:51119016 G>T), RS1000160233 (13:51124435 A>C), RS1000201993 (13:51125576 A>C,G), RS1000231855 (13:51136128 C>A,T), RS1000318932 (13:51112904 C>G), RS1000363138 (13:51155027 T>C), RS1000365982 (13:51088067 G>A), RS1000394637 (13:51087814 G>A), RS1000413516 (13:51102069 C>T), RS1000430008 (13:51161241 T>A), RS1000435114 (13:51154827 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST007978_3 | Postoperative atrial fibrillation after cardiac surgery | 1.000000e-06 |
| GCST009464_19 | Facial morphology | 1.000000e-08 |
| GCST012166_7 | Adiponectin levels | 8.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009951 | response to surgery |
| EFO:0009952 | post-operative atrial fibrillation |
| EFO:0004502 | adiponectin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases expression | 1 |
| benzo(e)pyrene | increases methylation | 1 |
| Methapyrilene | increases methylation | 1 |
| Thiram | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.